Literature DB >> 13536859

Psychosurgery; present indications and future prospects.

W FREEMAN.   

Abstract

Although the advent and widespread use of ataractic drugs has more or less eclipsed lobotomy as a method of dealing with severe psychotic states, variations and adaptations of the operation still can be used with benefit in certain pretty well defined circumstances."Chemical lobotomy" and regressive electroshock bring about alterations in behavior superficially resembling those of lobotomy, but without the changes in personality that are the object of lobotomy. These desirable changes consist in increased extraversion, decreased preoccupation with self and decreased sensitivity to the opinions of others. With restricted operations, undesirable changes-the "frontal lobe syndrome"-do not occur. OPERATIVE FAILURES ARE DUE TO THREE MAIN CAUSES: (a) Preoperative emotional deterioration; (b) progress of the underlying disease; (c) relapse, possibly due to inadequate operation. Lobotomy is advisable if the patient does not show sustained improvement after a year of active treatment by other indicated means. The operation often represents the turning point in effective treatment. After the first year of ineffective treatment valuable time is being lost, with danger of fixation and deterioration. Then it is safer to operate than to wait. The future of psychosurgery lies in prompt application, in favorable patients, of selective operations that will reverse the trend of illness. There is particular need for further exploration of the temporal lobes in the hope of finding some procedure that will suppress hallucinations. Some 90 per cent of patients remaining in hospitals after psychosurgery are experiencing hallucinations. If these phenomena can be eliminated without producing serious personality defects, another large field for the application of psychosurgery will be opened.

Entities:  

Keywords:  PSYCHOSURGERY

Mesh:

Year:  1958        PMID: 13536859      PMCID: PMC1512315     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  10 in total

1.  Neuropathological study of prefrontal lobotomy.

Authors:  S YOKOI
Journal:  J Neuropathol Exp Neurol       Date:  1957-04       Impact factor: 3.685

2.  Electroencephalographic rhythms from the depths of the parietal, occipital and temporal lobes in man.

Authors:  C W SEM-JACOBSEN; M C PETERSEN; H W DODGE; J A LAZARTE; C B HOLMAN
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1956-05

3.  Value of the Grantham lobotomy.

Authors:  F J AYD
Journal:  South Med J       Date:  1957-07       Impact factor: 0.954

4.  Loss of recent memory after bilateral hippocampal lesions.

Authors:  W B SCOVILLE; B MILNER
Journal:  J Neurol Neurosurg Psychiatry       Date:  1957-02       Impact factor: 10.154

5.  Frontal lobotomy 1936-1956: a follow-up study of 3000 patients from one to twenty years.

Authors:  W FREEMAN
Journal:  Am J Psychiatry       Date:  1957-04       Impact factor: 18.112

6.  [Transorbital lobotomy; results in 54 cases treated at a private hospital].

Authors:  J ARRUDA; J A FIGUEIREDO; P W LONGO
Journal:  Arq Neuropsiquiatr       Date:  1956-12       Impact factor: 1.420

7.  West Virginia lobotomy project.

Authors:  W FREEMAN; H W DAVIS; I C EAST; H S TAIT; S O JOHNSON; W B ROGERS
Journal:  J Am Med Assoc       Date:  1954-11-06

8.  Changes in behavior following lobotomy; the Malamud rating scale.

Authors:  W FREEMAN
Journal:  J Neuropathol Exp Neurol       Date:  1954-01       Impact factor: 3.685

9.  Prognosis in frontal lobotomy by use of the Malamud rating scale.

Authors:  W FREEMAN
Journal:  Am J Psychiatry       Date:  1953-02       Impact factor: 18.112

10.  Human sonar; the amygdaloid nucleus in relation to auditory hallucinations.

Authors:  W FREEMAN; J M WILLIAMS
Journal:  J Nerv Ment Dis       Date:  1952-11       Impact factor: 2.254

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.